Bleeding Associated With Antiarrhythmic Drugs in Patients With Atrial Fibrillation Using Direct Oral Anticoagulants: A Nationwide Population Cohort Study
Background This study investigated drug–drug interactions in patients with atrial fibrillation taking both a direct oral anticoagulant (DOAC) and an antiarrhythmic drug. Methods and Results Using data from the National Health Insurance database (2012–2018), we identified 78 805 patients with atrial...
Saved in:
| Main Authors: | Victor Chien‐Chia Wu, Chun‐Li Wang, Yu‐Chang Huang, Hui‐Tzu Tu, Yu‐Tung Huang, Chang‐Fu Kuo, Shao‐Wei Chen, Kuo‐Chun Hung, Ming‐Shien Wen, Shang‐Hung Chang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.033513 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients
by: Shu-Yu Yao, et al.
Published: (2025-03-01) -
Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
by: B. A. Tatarsky, et al.
Published: (2021-08-01) -
Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
by: V. L. Doshchitsin, et al.
Published: (2022-07-01) -
Antiarrhythmic drug use in atrial fibrillation among different European countries – as determined by a physician survey
by: Espen Fengsrud, et al.
Published: (2025-08-01) -
THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS
by: Yu. A. Bunin
Published: (2016-01-01)